Meanwhile, Yang et al. [23] have found that the application of intermittent endocrine treatment in elderly patients with advanced PCa is effective in reducing serum PSA and VEGF levels, regulating immune function, and promoting patients' quality of life, which is consistent with the results of this study. This evidence concerns the gene VEGFA and posterior cortical atrophy.